Success Stories: EB-1A Approved for a Postdoctoral Associate in California in the Field of Microbiology
Client’s Testimonial:
Thank you so much for your work. Again, I greatly appreciate the assistance you have provided me.
Position at the Time of Case Filing: Postdoctoral Associate
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: October 1st, 2014
Processing Time: 3 Months, 6 Days (6 Days after upgrading to Premium Processing)
In this case, the client that we had the pleasure of working with was a Postdoctoral Associate from China in the field of Microbiology. His specialized research has focused on immune-proteomics and vaccine development. Specifically, his research addresses some of our nation’s most pressing issues in understanding bacterial infections and combating them with vaccinations. His work had resulted in at least 11 peer-reviewed scientific articles, numerous presentations at national and international conferences, and 4 patents. At the time that his case was filed, his publications had been cited at least 124 times by researchers around the world, serving as apparent and objective evidence of his major influence and impact on the field of endeavor, in addition to his sustained international acclaim. He had also conducted 32 manuscript reviews for at least 15 distinctive, internationally circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “Antiviral treatments are used for all kinds of maladies, from influenza to herpes in the United States, and the prevalence of these treatments are increasing with each year. According to the Center for Disease Control and Prevention, vaccine manufacturers expect to produce between 138 and 145 million doses of influenza vaccine for the U.S. market this year, a dramatic increase from the initial estimate of 135-139 million. A country that relies so heavily on a standard vaccine procedure would do well to bring in top-tier minds like [client] to help push the industry forward into new and more highly effective ways of using such a ubiquitous treatment.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Microbiology, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 3 months and 6 days.